CD274 and neoplasm: Notably, among patients with stage III disease in our cohort, a higher proportion exhibited elevated PD-L1 expression, suggesting the potential for adopting neoadjuvant immunotherapy strategies to achieve tumor regression and enable subsequent surgical eradication.